Skip to content

Safety and Feasibility Evaluation of Robot Assisted Physiotherapy Exercises With REX

Safety and Feasibility Evaluation of Robot Assisted Physiotherapy Exercises With REX

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02417532
Acronym
RAPPER II
Enrollment
56
Registered
2015-04-15
Start date
2015-05-31
Completion date
2016-12-31
Last updated
2019-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injury

Brief summary

Prospective, Open label, single arm, non-randomized, non-comparative registry study of Robot-Assisted Physiotherapy Exercises with the REX Robot powered exercise system in patients with Spinal cord or other injury preventing unsupported patient ambulation.

Detailed description

The objective of this feasibility study is to evaluate the overall device safety when used in Spinal Cord Injury Hospitals or Rehabilitation Centers under the supervision of a physician and/or qualified rehabilitation specialists.

Interventions

DEVICERehabilitation using REX

Exercises of wheelchair dependent subjects using REX

Sponsors

Generic Devices Consulting, Inc.
CollaboratorINDUSTRY
Rex Bionics Plc
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
10 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Wheelchair user * Spinal Injury Levels of C4 down to L5 * Has no outstanding skin integrity issues that could be effected by the REX device * Should be between approximately 1.42m and 1.93m in height. More specifically, REX is able to accommodate the following limb lengths: * Upper leg length : 380 - 470 mm * Lower leg length : 366 - 470 mm * Heel position (Ankle to hind foot) : 40 - 92 mm * Floor to ankle height (To be measured while wearing the shoe to be used for mobilising in REX) : 96 - 116 mm * Has a skeletal hip width of 380 mm or less (limit imposed by REX) * Is between 40 kg and 100 kg weight (limits imposed by REX) * Has the manual dexterity to work a joystick * Sufficient passive range of motion in the Hip, Knee and Ankle of at least * Hip 90 degrees flexion 15 degrees hip extension 20 degrees abduction 16 degrees adduction * Knee 0 degrees extension 93 degrees flexion * Ankle 20 degrees dorsiflexion (with weight bearing and 10 degrees knee flexion) 22 degrees dorsiflexion (with 93 degrees knee flexion) 10 degrees plantar flexion 9 degrees inversion 9 degrees eversion * Thigh lateral diameter of \< 135 mm (230 mm above the knee joint line) * Calf lateral diameter of \< 100 mm (90 mm below the knee joint line) * Manual dexterity to work a joystick with or without a T-Bar and use emergency stop button * No contraindications to standing or mobilising * Patients must choose to participate, and must have signed the informed consent document

Exclusion criteria

* Patients who do not meet inclusion criteria or physician discretion. * Patients with history of impaired cardiac function who have been referred to and reviewed by a medical professional. With a decision made that they should not continue in the trial due to their impaired cardiac function. * Patients contraindicated to walk or stand * Patients with spinal injury outside Inclusion criteria * Withdrawal or refusal to sign informed consent * Any other contraindication based on physician discretion * Known allergy (skin contact) to materials used in Rex

Design outcomes

Primary

MeasureTime frameDescription
Ability to Transfer1 dayCompletion of transfer with supervision or 1 assistant from wheelchair or bed into REX
Adverse Events1 dayabsence of unexpected serious adverse events
Transfer Time1 dayTime it took for participant to transfer into the Rex with or without supervision.

Secondary

MeasureTime frameDescription
Participant Satisfaction Questionnaire1 Dayoverall user satisfaction with the device
Timed up and go Test- Ability to Stand From Chair1 DayThe number of seconds required to walk 3 m and turn around and walk back to the chair. (Functional test)

Countries

Australia, New Zealand, United Kingdom

Participant flow

Participants by arm

ArmCount
Rehabilitation Using REX
Exercises using Rex mobility assist device Rehabilitation using REX: Exercises of wheelchair dependent subjects using REX
56
Total56

Baseline characteristics

CharacteristicRehabilitation Using REX
Age, Categorical
<=18 years
1 Participants
Age, Categorical
>=65 years
1 Participants
Age, Categorical
Between 18 and 65 years
54 Participants
Age, Continuous39.8 years
Region of Enrollment
Australia
44 participants
Region of Enrollment
New Zealand
3 participants
Region of Enrollment
United Kingdom
9 participants
Sex: Female, Male
Female
19 Participants
Sex: Female, Male
Male
37 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 56
other
Total, other adverse events
0 / 56
serious
Total, serious adverse events
0 / 56

Outcome results

Primary

Ability to Transfer

Completion of transfer with supervision or 1 assistant from wheelchair or bed into REX

Time frame: 1 day

Population: All subjects meeting inclusion criteria. Physically able to properly fit in REX.

ArmMeasureValue (NUMBER)
Rehabilitation Using REXAbility to Transfer32 participants
Primary

Adverse Events

absence of unexpected serious adverse events

Time frame: 1 day

Population: All patients transferring into Rex.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Rehabilitation Using REXAdverse Events56 Participants
Primary

Transfer Time

Time it took for participant to transfer into the Rex with or without supervision.

Time frame: 1 day

Population: All patients transferring into Rex

ArmMeasureValue (MEDIAN)Dispersion
Rehabilitation Using REXTransfer Time352.2 secondsStandard Deviation 75
Secondary

Participant Satisfaction Questionnaire

overall user satisfaction with the device

Time frame: 1 Day

Population: Patients who were able to transfer into REX and who could control the joystick. One patient was unable to walk and control Rex so did not complete the questionaire.

ArmMeasureGroupValue (NUMBER)
Rehabilitation Using REXParticipant Satisfaction QuestionnaireEasy to Transfer % positive57 percentage of patients
Rehabilitation Using REXParticipant Satisfaction QuestionnaireConfidence % positive91 percentage of patients
Rehabilitation Using REXParticipant Satisfaction QuestionnaireSafety % positive88 percentage of patients
Rehabilitation Using REXParticipant Satisfaction QuestionnaireStability % positive89 percentage of patients
Rehabilitation Using REXParticipant Satisfaction QuestionnaireEase of control % positive84 percentage of patients
Rehabilitation Using REXParticipant Satisfaction QuestionnaireComfort % positive84 percentage of patients
Rehabilitation Using REXParticipant Satisfaction QuestionnaireWellbeing following use % positive82 percentage of patients
Rehabilitation Using REXParticipant Satisfaction QuestionnaireBenefits to using regularly % positive91 percentage of patients
Rehabilitation Using REXParticipant Satisfaction QuestionnaireThe size of REX did not bother me64 percentage of patients
Rehabilitation Using REXParticipant Satisfaction QuestionnaireThe sound of REX did not bother me % positive73 percentage of patients
Rehabilitation Using REXParticipant Satisfaction QuestionnaireThe speed of REX was suitable for me % positive61 percentage of patients
Secondary

Timed up and go Test- Ability to Stand From Chair

The number of seconds required to walk 3 m and turn around and walk back to the chair. (Functional test)

Time frame: 1 Day

Population: Subjects who were able to control the joystick. One patient was unable to control the joystick and was excluded.

ArmMeasureValue (MEAN)Dispersion
Rehabilitation Using REXTimed up and go Test- Ability to Stand From Chair316.41 secondsStandard Deviation 91.52

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026